ERBB2 and breast cancer: Western blotting showed that Compound C inhibited the expression of aspirin-activated p-AMPKα in AU-565 and BT-474 breast cancer cells (Figure 2B) and HER-2-negative breast cancer MDA-MB-231 breast cancer cells (Supplementary Figure 1A).